These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36934527)

  • 1. Design and synthesis of novel GluN2A NMDAR positive allosteric modulators via scaffold hopping strategy as anti-stroke therapeutic agents.
    Chen X; Zhu H; Liu X; Li Q; Dong M
    Bioorg Med Chem; 2023 Apr; 83():117236. PubMed ID: 36934527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of a novel negative allosteric modulator of NMDA receptors, UBP792.
    Sapkota K; Burnell ES; Irvine MW; Fang G; Gawande DY; Dravid SM; Jane DE; Monaghan DT
    Neuropharmacology; 2021 Dec; 201():108818. PubMed ID: 34610288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel positive allosteric modulators targeting GluN1/2A NMDARs as anti-stroke therapeutic agents.
    Zhu H; Chen X; Zhang L; Liu X; Chen J; Zhang HT; Dong M
    RSC Med Chem; 2024 Apr; 15(4):1307-1319. PubMed ID: 38665828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.
    Sakurai F; Yukawa T; Kina A; Murakami M; Takami K; Morimoto S; Seto M; Kamata M; Yamashita T; Nakashima K; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T
    Bioorg Med Chem; 2022 Feb; 56():116576. PubMed ID: 35051811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel family of negative and positive allosteric modulators of NMDA receptors.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity.
    Zhou X; Ding Q; Chen Z; Yun H; Wang H
    J Biol Chem; 2013 Aug; 288(33):24151-9. PubMed ID: 23839940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
    Yi F; Rouzbeh N; Hansen KB; Xu Y; Fanger CM; Gordon E; Paschetto K; Menniti FS; Volkmann RA
    Neuropharmacology; 2020 Aug; 173():107971. PubMed ID: 31987864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
    Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
    [No Abstract]   [Full Text] [Related]  

  • 9. The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca
    Perszyk RE; Zheng Z; Banke TG; Zhang J; Xie L; McDaniel MJ; Katzman BM; Pelly SC; Yuan H; Liotta DC; Traynelis SF
    Mol Pharmacol; 2021 May; 99(5):399-411. PubMed ID: 33688039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GluN2A-NMDA receptor-mediated sustained Ca
    Deep SN; Mitra S; Rajagopal S; Paul S; Poddar R
    J Biol Chem; 2019 Jul; 294(29):11154-11165. PubMed ID: 31167782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triclosan-Evoked Neurotoxicity Involves NMDAR Subunits with the Specific Role of GluN2A in Caspase-3-Dependent Apoptosis.
    Szychowski KA; Wnuk A; Rzemieniec J; Kajta M; Leszczyńska T; Wójtowicz AK
    Mol Neurobiol; 2019 Jan; 56(1):1-12. PubMed ID: 29675573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitotoxicity and stroke: identifying novel targets for neuroprotection.
    Lai TW; Zhang S; Wang YT
    Prog Neurobiol; 2014 Apr; 115():157-88. PubMed ID: 24361499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
    Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE
    Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.
    Xu Q; Hu M; Li J; Ma X; Chu Z; Zhu Q; Zhang Y; Zhu P; Huang Y; He G
    Eur J Med Chem; 2022 Jan; 227():113876. PubMed ID: 34710748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
    Yi F; Bhattacharya S; Thompson CM; Traynelis SF; Hansen KB
    J Physiol; 2019 Nov; 597(22):5495-5514. PubMed ID: 31541561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
    Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
    Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.
    Irvine MW; Fang G; Sapkota K; Burnell ES; Volianskis A; Costa BM; Culley G; Collingridge GL; Monaghan DT; Jane DE
    Eur J Med Chem; 2019 Feb; 164():471-498. PubMed ID: 30622023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.